NATIONALINSTITUTE FOR HEALTH AND CLINICALEXCELLENCE
Publisher:
NationalInstitute for Health and ClinicalExcellence
Publication year:
2006
Pagination:
41p.
Place of publication:
London
This costing report looks at the resource impact of implementing the NICE-SCIE guideline ‘Dementia: supporting people with dementia and their carers in health and social care’ in England. Due to the complexity of this guideline, this report focuses on the recommendations that are considered to have a significant impact on resources and will therefore require the additional resources to implement or that will generate savings. The recommendations that are included in the cost template are the increases in psychological therapy offered to carers of people with dementia, structural imaging requirements, and a reduction in the use of electroencephalograms (EEGs). Other recommendations, such as those relating to the coordination and integration of health and social care, were also considered, but the cost implications were not included in this report due to varying baseline practice across organisations. The report calculates the cost of fully implementing this guideline to be £40.63 million. However, it states that it is reasonable to expect that additional costs will be incurred over and above those identified by the assessment.
This costing report looks at the resource impact of implementing the NICE-SCIE guideline ‘Dementia: supporting people with dementia and their carers in health and social care’ in England. Due to the complexity of this guideline, this report focuses on the recommendations that are considered to have a significant impact on resources and will therefore require the additional resources to implement or that will generate savings. The recommendations that are included in the cost template are the increases in psychological therapy offered to carers of people with dementia, structural imaging requirements, and a reduction in the use of electroencephalograms (EEGs). Other recommendations, such as those relating to the coordination and integration of health and social care, were also considered, but the cost implications were not included in this report due to varying baseline practice across organisations. The report calculates the cost of fully implementing this guideline to be £40.63 million. However, it states that it is reasonable to expect that additional costs will be incurred over and above those identified by the assessment.
NATIONALINSTITUTE FOR HEALTH AND CLINICALEXCELLENCE
Publisher:
NationalInstitute for Health and ClinicalExcellence
Publication year:
2006
Pagination:
22p.
Place of publication:
London
This document provides practical advice to help the NHS and social care organisations implement the NICE/SCIE guideline ‘Dementia: supporting people with dementia and their carers in health and social care’. It aims to help implementers develop an action plan and should be used alongside the costing tools and audit criteria developed for this guideline. The following steps to implement the guideline are discussed: check if the guideline is relevant; identify implementation leads; identify an implementation group; carry out a baseline assessment; assess costs and savings; and develop an action plan. Three key areas for implementation are: integrated and coordinated commissioning; service provision such as memory assessment services and structural imaging; and communication, education and training. An example action plan is provided. The implementation advice applies to services based in England, and the practice messages in the guidelines can also be used by managers and practitioners in Wales and Northern Ireland.
This document provides practical advice to help the NHS and social care organisations implement the NICE/SCIE guideline ‘Dementia: supporting people with dementia and their carers in health and social care’. It aims to help implementers develop an action plan and should be used alongside the costing tools and audit criteria developed for this guideline. The following steps to implement the guideline are discussed: check if the guideline is relevant; identify implementation leads; identify an implementation group; carry out a baseline assessment; assess costs and savings; and develop an action plan. Three key areas for implementation are: integrated and coordinated commissioning; service provision such as memory assessment services and structural imaging; and communication, education and training. An example action plan is provided. The implementation advice applies to services based in England, and the practice messages in the guidelines can also be used by managers and practitioners in Wales and Northern Ireland.
Subject terms:
planning, policy, social care provision, Alzheimers disease, carers, commissioning, costs, dementia, diagnosis, health care;
NATIONALINSTITUTE FOR HEALTH AND CLINICALEXCELLENCE
Publisher:
NationalInstitute for Health and ClinicalExcellence
Publication year:
2006
Pagination:
tables
Place of publication:
London
This costing template is designed to support the costing report which looks at implementing the NICE-SCIE guideline ‘Dementia: supporting people with dementia and their carers in health and social care’ in England. Due to the complexity of this guideline, the report focuses on the recommendations that are considered to have a significant impact on resources and will therefore require the additional resources to implement or that will generate savings. The recommendations included in the cost template are the increases in psychological therapy offered to carers of people with dementia, structural imaging requirements, and a reduction in the use of electroencephalograms (EEGs). The costing template enables organisations such as primary care trusts to estimate the budget impact locally and replace variables with ones that depict the current local position. Using the template involves a 3 stage process: selecting the local population; adapting the costing template to reflect local circumstances; and reviewing the costing report. The aim of the costing template is to assist in assessing the resource impact of the guideline at a local level.
This costing template is designed to support the costing report which looks at implementing the NICE-SCIE guideline ‘Dementia: supporting people with dementia and their carers in health and social care’ in England. Due to the complexity of this guideline, the report focuses on the recommendations that are considered to have a significant impact on resources and will therefore require the additional resources to implement or that will generate savings. The recommendations included in the cost template are the increases in psychological therapy offered to carers of people with dementia, structural imaging requirements, and a reduction in the use of electroencephalograms (EEGs). The costing template enables organisations such as primary care trusts to estimate the budget impact locally and replace variables with ones that depict the current local position. Using the template involves a 3 stage process: selecting the local population; adapting the costing template to reflect local circumstances; and reviewing the costing report. The aim of the costing template is to assist in assessing the resource impact of the guideline at a local level.
Subject terms:
models, policy, psychotherapy, carers, costs, dementia, diagnosis, expenditure, health care;
NATIONALINSTITUTE FOR HEALTH AND CLINICALEXCELLENCE
Publisher:
NationalInstitute for Health and ClinicalExcellence
Publication year:
2006
Pagination:
17p.
Place of publication:
London
This document advices on audit criteria to assist NHS acute and primary care trusts and social care providers to determine whether the service is implementing, and is in compliance with, the NICE-SCIE guideline ‘Dementia: supporting people with dementia and their carers in health and social care’. It advises that the audit should ideally cover a sample of 100 people presenting with dementia, or suspected dementia, over a period of 12 months. The audit criteria require data to be collected from a range of sources, including policy documents, patient health records and health and social care plans. The audit should be repeated periodically in order to allow organisations to monitor progress towards full compliance.
This document advices on audit criteria to assist NHS acute and primary care trusts and social care providers to determine whether the service is implementing, and is in compliance with, the NICE-SCIE guideline ‘Dementia: supporting people with dementia and their carers in health and social care’. It advises that the audit should ideally cover a sample of 100 people presenting with dementia, or suspected dementia, over a period of 12 months. The audit criteria require data to be collected from a range of sources, including policy documents, patient health records and health and social care plans. The audit should be repeated periodically in order to allow organisations to monitor progress towards full compliance.
Subject terms:
needs assessment, older people, performance evaluation, policy, psychotherapy, carers, care planning, data collection, dementia, diagnosis;
NATIONALINSTITUTE FOR HEALTH AND CLINICALEXCELLENCE
Publisher:
NationalInstitute for Health and ClinicalExcellence
Publication year:
2011
Place of publication:
Manchester
The NICE quality standard for service user experience in adult mental health sets out how a high-quality mental health service should be organised, so that the best care can be offered to people using NHS services in England. It defines best practice within this topic area, and provides 15 specific, concise quality statements, measures and audience descriptors to provide the public, mental health and social care professionals, commissioners and service providers with definitions of high-quality care. In addition, quality standards that should also be considered when commissioning and providing adult mental health services are listed in related NICE quality standards. This quality standard does not cover mental health service users using NHS services for physical health problems, or the experiences of families or carers of people using NHS services specifically.
(Edited publisher abstract)
The NICE quality standard for service user experience in adult mental health sets out how a high-quality mental health service should be organised, so that the best care can be offered to people using NHS services in England. It defines best practice within this topic area, and provides 15 specific, concise quality statements, measures and audience descriptors to provide the public, mental health and social care professionals, commissioners and service providers with definitions of high-quality care. In addition, quality standards that should also be considered when commissioning and providing adult mental health services are listed in related NICE quality standards. This quality standard does not cover mental health service users using NHS services for physical health problems, or the experiences of families or carers of people using NHS services specifically.
(Edited publisher abstract)
Subject terms:
adults, mental health services, NHS, service users, quality assurance, standards, good practice;
NATIONALINSTITUTE FOR HEALTH AND CLINICALEXCELLENCE
Publisher:
NationalInstitute for Health and ClinicalExcellence
Publication year:
2013
Pagination:
45
Despite improvements in mortality and morbidity, people with stroke need access to effective rehabilitation services. Stroke rehabilitation is a multidimensional process, which is designed to facilitate restoration of, or adaptation to the loss of, physiological or psychological function when reversal of the underlying pathological process is incomplete. Rehabilitation aims to enhance functional activities and participation in society and thus improve quality of life. Key aspects of rehabilitation care include multidisciplinary assessment, identification of functional difficulties and their measurement, treatment planning through goal setting, delivery of interventions which may either effect change or support the person in managing persisting change, and evaluation of effectiveness. This guideline reviews some of the available interventions that can be used in stroke rehabilitation. The full guideline, 'Stroke rehabilitation: long term rehabilitation after stroke' contains details of the methods and evidence used to develop the guideline.
(Edited publisher abstract)
Despite improvements in mortality and morbidity, people with stroke need access to effective rehabilitation services. Stroke rehabilitation is a multidimensional process, which is designed to facilitate restoration of, or adaptation to the loss of, physiological or psychological function when reversal of the underlying pathological process is incomplete. Rehabilitation aims to enhance functional activities and participation in society and thus improve quality of life. Key aspects of rehabilitation care include multidisciplinary assessment, identification of functional difficulties and their measurement, treatment planning through goal setting, delivery of interventions which may either effect change or support the person in managing persisting change, and evaluation of effectiveness. This guideline reviews some of the available interventions that can be used in stroke rehabilitation. The full guideline, 'Stroke rehabilitation: long term rehabilitation after stroke' contains details of the methods and evidence used to develop the guideline.
(Edited publisher abstract)
Subject terms:
stroke, rehabilitation, long term care, health care, social care, intervention;
NATIONALINSTITUTE FOR HEALTH AND CLINICALEXCELLENCE
Publisher:
NationalInstitute for Health and ClinicalExcellence
Publication year:
2013
Place of publication:
London
This guideline is concerned with the recognition and management of psychosis and schizophrenia in children and young people up to the age of 18 years. Psychotic disorders such as schizophrenia are major psychiatric disorders that alter a person’s perception, thoughts, mood and behaviour. The prevalence of psychotic disorders in children aged 5-18 years is estimated to be 0.4%. Schizophrenia accounts for 24.5% of all psychiatric admissions in young people aged 10-18 years with an exponential rise across the adolescent years. This guideline covers the care provided by primary, community, secondary, tertiary and other health and social care professionals who have direct contact with, and make decisions concerning, the care of children and young people with psychosis or schizophrenia, including child and adolescent mental health services (CAMHS) and early intervention in psychosis services. The following recommendations are identified as priorities for implementation: treatment options for symptoms not sufficient for a diagnosis of psychosis or schizophrenia; referral from primary care for first episode psychosis; treatment options for first episode psychosis; how to use oral antipsychotic medication; treatment of subsequent acute episodes of psychosis or schizophrenia; and education, employment and occupational activities for children and young people with psychosis and schizophrenia.
This guideline is concerned with the recognition and management of psychosis and schizophrenia in children and young people up to the age of 18 years. Psychotic disorders such as schizophrenia are major psychiatric disorders that alter a person’s perception, thoughts, mood and behaviour. The prevalence of psychotic disorders in children aged 5-18 years is estimated to be 0.4%. Schizophrenia accounts for 24.5% of all psychiatric admissions in young people aged 10-18 years with an exponential rise across the adolescent years. This guideline covers the care provided by primary, community, secondary, tertiary and other health and social care professionals who have direct contact with, and make decisions concerning, the care of children and young people with psychosis or schizophrenia, including child and adolescent mental health services (CAMHS) and early intervention in psychosis services. The following recommendations are identified as priorities for implementation: treatment options for symptoms not sufficient for a diagnosis of psychosis or schizophrenia; referral from primary care for first episode psychosis; treatment options for first episode psychosis; how to use oral antipsychotic medication; treatment of subsequent acute episodes of psychosis or schizophrenia; and education, employment and occupational activities for children and young people with psychosis and schizophrenia.
Subject terms:
medication, mental health care, psychoses, psychotherapy, schizophrenia, young people, child and adolescent mental health services, children, early intervention;
NATIONALINSTITUTE FOR HEALTH AND CLINICALEXCELLENCE
Publisher:
British Psychological Society; Royal College of Psychiatrists
Publication year:
2013
Pagination:
4 documents
Place of publication:
London
This guideline is concerned with the recognition and management of psychosis and schizophrenia in children and young people up to the age of 18 years. Psychotic disorders such as schizophrenia are major psychiatric disorders that alter a person’s perception, thoughts, mood and behaviour. The prevalence of psychotic disorders in children aged 5-18 years is estimated to be 0.4%. Schizophrenia accounts for 24.5% of all psychiatric admissions in young people aged 10-18 years with an exponential rise across the adolescent years. The guideline covers the care provided by primary, community, secondary, tertiary and other health and social care professionals who have direct contact with, and make decisions concerning, the care of children and young people with psychosis or schizophrenia, including child and adolescent mental health services (CAMHS) and early intervention in psychosis services. This record links to 4 appendices from the guideline: appendix 13: clinical evidence - included study characteristics tables; appendix 14: clinical evidence Forest Plots; appendix 15: economic evidence - completed methodology checklists; appendix 16: economic evidence - evidence tables of published studies; and appendix 17: clinical and economic evidence profiles.
This guideline is concerned with the recognition and management of psychosis and schizophrenia in children and young people up to the age of 18 years. Psychotic disorders such as schizophrenia are major psychiatric disorders that alter a person’s perception, thoughts, mood and behaviour. The prevalence of psychotic disorders in children aged 5-18 years is estimated to be 0.4%. Schizophrenia accounts for 24.5% of all psychiatric admissions in young people aged 10-18 years with an exponential rise across the adolescent years. The guideline covers the care provided by primary, community, secondary, tertiary and other health and social care professionals who have direct contact with, and make decisions concerning, the care of children and young people with psychosis or schizophrenia, including child and adolescent mental health services (CAMHS) and early intervention in psychosis services. This record links to 4 appendices from the guideline: appendix 13: clinical evidence - included study characteristics tables; appendix 14: clinical evidence Forest Plots; appendix 15: economic evidence - completed methodology checklists; appendix 16: economic evidence - evidence tables of published studies; and appendix 17: clinical and economic evidence profiles.
Subject terms:
medication, mental health care, psychoses, psychotherapy, schizophrenia, young people, child and adolescent mental health services, children, early intervention;
NATIONALINSTITUTE FOR HEALTH AND CLINICALEXCELLENCE
Publisher:
National Institute for Clinical Excellence
Publication year:
2010
Place of publication:
London
Produced at the request of the Department of Health, this public health guidance on the prevention and early identification of alcohol-use disorders among adults and adolescents is intended for those working in the NHS, local authorities, the wider public, voluntary and community sectors, and the private sector. It sets out the NationalInstitute for Health and ClinicalExcellence recommendations
Produced at the request of the Department of Health, this public health guidance on the prevention and early identification of alcohol-use disorders among adults and adolescents is intended for those working in the NHS, local authorities, the wider public, voluntary and community sectors, and the private sector. It sets out the NationalInstitute for Health and ClinicalExcellence recommendations for reducing alcohol-related harm. These include recommendations for policy (covering price, availability, and marketing) and recommendations for practice (covering licensing, screening of people who may be at risk of harm from the amount of alcohol they drink, brief interventions, structured brief advice and extended brief interventions, and supporting children and young people). The guidance also looks at public health need and practice, considerations, implementation and recommendations for research, and includes the evidence statements underpinning the recommendations. A separate reference guide for professionals and the public is also available.
Subject terms:
intervention, prevention, public health, social policy, young people, adults, alcohol misuse, good practice;
NATIONALINSTITUTE FOR HEALTH AND CLINICALEXCELLENCE
Publisher:
NationalInstitute for Health and ClinicalExcellence
Publication year:
2007
Pagination:
48p.
Place of publication:
London
This NICE guideline makes recommendations for the prediction, detection and treatment of mental disorders in women during pregnancy and the postnatal period (up to 1 year after delivery). It includes advice on the care of women with an existing mental disorder who are planning a pregnancy, and on the organisation of mental health services. The guideline covers the care of women with anxiety disorders, and depression. It also covers the treatment of postnatal psychotic disorders (often referred to as puerperal psychosis), which predominantly comprise bipolar disorder and schizophrenia. It includes advice on the teratogenic risk of psychotropic medications and on the risks of their use during breastfeeding. The focus is on balancing the risks for each woman and her child against those of leaving the mental disorder untreated or inadequately treated. The guidance is based on the best available evidence but points to the limited evidence base in some areas. It is noted that no psychotropic drug has marketing authorisation specifically for pregnant or breastfeeding women. The guideline is intended to be read in conjunction with existing NICE guidance on the treatment and management of mental disorders which also includes advice on the most appropriate organisation of services for the delivery of effective treatment within a stepped-care framework.
This NICE guideline makes recommendations for the prediction, detection and treatment of mental disorders in women during pregnancy and the postnatal period (up to 1 year after delivery). It includes advice on the care of women with an existing mental disorder who are planning a pregnancy, and on the organisation of mental health services. The guideline covers the care of women with anxiety disorders, and depression. It also covers the treatment of postnatal psychotic disorders (often referred to as puerperal psychosis), which predominantly comprise bipolar disorder and schizophrenia. It includes advice on the teratogenic risk of psychotropic medications and on the risks of their use during breastfeeding. The focus is on balancing the risks for each woman and her child against those of leaving the mental disorder untreated or inadequately treated. The guidance is based on the best available evidence but points to the limited evidence base in some areas. It is noted that no psychotropic drug has marketing authorisation specifically for pregnant or breastfeeding women. The guideline is intended to be read in conjunction with existing NICE guidance on the treatment and management of mental disorders which also includes advice on the most appropriate organisation of services for the delivery of effective treatment within a stepped-care framework.
Subject terms:
mental health care, mental health problems, postnatal depression, pregnancy, schizophrenia, antipsychotic medication, anxiety, bipolar disorder, good practice;